Biomarkers of traumatic brain injury have long been investigated, yet their application in real life clinical practice is less than widespread.
Research efforts under the umbrella of InTBIR and specifically CENTER TBI provided novel results based on a bulk of data collected.
The symposium aims to provide an update on contemporary knowledge on purported clinical application of core biomarkers while also sharing novel data on emerging markers and novel technologies and approaches that may further improve our diagnostic and prognostic capabilities in the treatment of traumatic brain injury.
The session will provide a critical review and update on biomarkers of spinal cord injury.